Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.42 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.41 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5447729 | 0.93 | FAAH (0.88) | FAAHPOLBMAOBALDH1A1CYP1A2 | |
| SCHEMBL14627810 | 0.88 | FAAH (0.79) | FAAHPOLBALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL5454086 | 0.87 | FAAH (0.77) | FAAHSMN1; SMN2ENPP2LMNA | |
| SCHEMBL5450185 | 0.87 | FAAH (0.77) | FAAHMAOBALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL5453621 | 0.83 | FAAH (0.70) | FAAHMAOBALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL2463633 | 0.82 | FAAH (0.69) | FAAHPOLBALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL5455256 | 0.81 | FAAH (0.68) | FAAHSMN1; SMN2ENPP2LMNA | |
| SCHEMBL5453583 | 0.81 | FAAH (0.67) | FAAHMAOBENPP2P2RX3 | |
| SCHEMBL5453555 | 0.80 | FAAH (0.66) | FAAHMAOBSMN1; SMN2 | |
| SCHEMBL20015397 | 0.80 | FAAH (0.66) | FAAHMAOBALDH1A1KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109732-A1 | LIPID AMINES | MODERNATX INC (US) | 2026-04-23 | — | — | US | claimed |
| EP-4376952-A1 | ANTI-SIRP-ALPHA ANTIBODIES AND METHODS OF USE THEREOF | Alector LLC (US) | 2024-06-05 | — | — | EP | claimed |
| CN-107814161-B | Cake assembly line synthesizing equipment | 福建省然利食品集团有限公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2023010076-A1 | ANTI-SIRP-ALPHA ANTIBODIES AND METHODS OF USE THEREOF | ALECTOR LLC (US) | 2023-02-02 | — | — | WO | claimed |
| US-20260109732-A1 | LIPID AMINES | MODERNATX INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12599600-B2 | Compositions and methods for preventing and treating headache through enhancing 2-arachydonyl glyerol activity | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2026-04-14 | — | — | US | disclosed |
| US-12515253-B2 | Compositions, comprising silver nanoplatelets | BASF SE (DE) | 2026-01-06 | — | — | US | disclosed |
| EP-4660199-A1 | 19-NOR NEUROACTIVE STEROIDS FOR INDUCING SEDATION | Sage Therapeutics, Inc. (US) | 2025-12-10 | — | — | EP | disclosed |
| US-20250235531-A1 | MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS | MODERNATX, INC. (US) | 2025-07-24 | — | — | US | disclosed |
| US-20250205175-A1 | Anti-Aging Composition with mTOR inhibitor for Humans and Other Mammals | POSTREL RICHARD (US) | 2025-06-26 | — | — | US | disclosed |
| US-20250152562-A1 | Compositions to Enhance and Extend Quality of Life | POSTREL RICHARD (US) | 2025-05-15 | — | — | US | disclosed |
| US-12280019-B2 | Anti-aging therapy for humans and other mammals | POSTREL RICHARD (US) | 2025-04-22 | — | — | US | disclosed |
| US-20220175694-A1 | Anti-Aging Therapy for Canines and Other Domesticated Animals | POSTREL RICHARD (US) | 2022-06-09 | — | — | US | disclosed |
| EP-3996702-A1 | PIEZO AGONISTS FOR PREVENTING OR REVERTING ABNORMAL AMYLOID DEPOSITION | Itä-Suomen Yliopisto (FI) | 2022-05-18 | — | — | EP | disclosed |
| US-11331300-B2 | Reversing baldness through follicle regeneration | POSTREL RICHARD (US) | 2022-05-17 | — | — | US | disclosed |
| US-11318093-B2 | Dental topical anesthetic gel | PAC-DENT, INC. | 2022-05-03 | — | — | US | disclosed |
| CN-114126617-A | Piezoelectric agonists for preventing or reversing abnormal amyloid deposition | 东芬兰大学 | 2022-03-01 | — | — | CN | disclosed |
| US-11261211-B2 | 19-NOR neuroactive steroids and methods of use thereof | SAGE THERAPEUTICS, INC. (US) | 2022-03-01 | — | — | US | disclosed |
| US-11253594-B2 | Drug combinations for protecting against neuronal cell death | UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2022-02-22 | — | — | US | disclosed |
| US-20070021405-A1 | ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS | SANOFI-AVENTIS (FR) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021405-A1 | ARYL- AND HETEROARYLPIPERIDINECARBOXYLATE-DERIVATIVES METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS | FAAH, FAAH2, HRH2 | FAAH 1/4885POLB 2598/4885MAOB 265/4885 |
| US-12599600-B2 | Compositions and methods for preventing and treating headache through enhancing 2-arachydonyl glyerol activity | FAAH2, PTGS2, PTGES2 | FAAH 6/4885POLB 4157/4885MAOB 1333/4885 |
| US-20250235531-A1 | MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS | MUC1, RNMT, FABP2 | FAAH 2174/4885POLB 612/4885MAOB 3505/4885 |
| US-11253594-B2 | Drug combinations for protecting against neuronal cell death | NLN, CASP3, BAX | FAAH 1839/4885POLB 3031/4885MAOB 854/4885 |
| US-11261211-B2 | 19-NOR neuroactive steroids and methods of use thereof | NR3C2, HSD3B1, NR3C1 | FAAH 293/4885POLB 3614/4885MAOB 474/4885 |
| US-20260109732-A1 | LIPID AMINES | LDLR, NPC1, PHOSPHO1 | FAAH 886/4885POLB 3025/4885MAOB 1873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.